Amended Statement of Ownership (sc 13g/a)
January 18 2019 - 6:07AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
APYX MEDICAL
CORPORATION
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
03837C106
(CUSIP Number)
December 31, 2018
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:
☐ Rule
13d-1(b)
☒ Rule
13d-1(c)
☐ Rule
13d-1(d)
*
|
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form
with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities
Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
CUSIP No. 03837C106
|
|
13G
|
|
Page
2
of 5 Pages
|
|
|
|
|
|
|
|
1.
|
|
NAMES OF REPORTING PERSONS
William Weeks Vanderfelt
|
2.
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (see instructions)
(a) ☐ (b) ☒
|
3.
|
|
SEC USE ONLY
|
4.
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
United
Kingdom
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5.
|
|
SOLE VOTING POWER
0
|
|
6.
|
|
SHARED VOTING POWER
2,850,000
|
|
7.
|
|
SOLE DISPOSITIVE POWER
0
|
|
8.
|
|
SHARED DISPOSITIVE POWER
2,850,000
|
|
|
|
|
|
|
|
9.
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,850,000
|
10.
|
|
CHECK IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)
☐
|
11.
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
8.6% (1)
|
12.
|
|
TYPE OF REPORTING PERSON
(see instructions)
IN
|
(1)
|
The percentage set forth in Row 11 of this Cover Page is based on the 33,203,517 shares of Common Stock (as
defined herein) of the Issuer (as defined herein) outstanding as of October 29, 2018, as reported in the Issuers Form
10-Q
filed with the Securities and Exchange Commission on November 2, 2018.
|
|
|
|
|
|
CUSIP No. 03837C106
|
|
13G
|
|
Page
3
of 5 Pages
|
Item 1.
Apyx Medical Corporation (f/k/a Bovie Medical Corporation)
|
(b)
|
Address of Issuers principal executive offices
|
5115 Ulmerton Road, Clearwater, FL 33760
Item 2.
|
(a)
|
Name of person filing
|
This Amendment No. 3 to the Schedule 13G filed on September 13, 2016 (as amended by Amendment No. 1 thereto filed on
February 10, 2017 and Amendment No. 2 thereto filed on February 9, 2018) is being filed on behalf of William Weeks Vanderfelt with respect to the shares of Common Stock, $0.001 par value per share (the
Common
Stock
), of Apyx Medical Corporation, a Delaware corporation (f/k/a Bovie Medical Corporation, the
Issuer
).
|
(b)
|
Address or principal business office or, if none, residence
|
Coralis 44, Azzuri Village 44, Roches Noires, 31201 Mauritius
See Row 4 of the Cover Page.
|
(d)
|
Title of class of securities
|
Common Stock, par value $0.001 per share
03837C106
Item 3. If this
statement is filed pursuant to
§§240.13d-1(b)
or
240.13d-2(b)
or (c), check whether the person filing is a:
|
(a)
|
☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
|
(b)
|
☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
(c)
|
☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
(d)
|
☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C.
80a-8).
|
|
(e)
|
☐ An investment adviser in accordance with
§240.13d-1(b)(1)(ii)(E);
|
|
(f)
|
☐ An employee benefit plan or endowment fund in accordance with
§240.13d-1(b)(1)(ii)(F);
|
|
(g)
|
☐ A parent holding company or control person in accordance with
§240.13d-1(b)(1)(ii)(G);
|
|
(h)
|
☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12
U.S.C. 1813);
|
|
(i)
|
☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14)
of the Investment Company Act of 1940 (15 U.S.C.
80a-3);
|
|
(j)
|
☐ A
non-U.S.
institution in accordance with Rule
13d-1(b)(1)(ii)(J);
|
|
(k)
|
☐ Group, in accordance with
§240.13d-1(b)(1)(ii)(K).
|
|
|
|
|
|
CUSIP No. 03837C106
|
|
13G
|
|
Page
4
of 5 Pages
|
If filing as a
non-U.S.
institution in accordance with Rule
13d-1(b)(1)(ii)(J),
please specify the type of institution:
Item 4. Ownership.
The information required by Items 4(a)-(c) is set forth in Rows
5-11
of the Cover Page and is incorporated herein by
reference.
Item 5. Ownership of 5 Percent or Less of a Class.
Not applicable.
Item 6. Ownership of More than 5
Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or
Control Person.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of
Group.
Not applicable.
Item 10. Certification.
By signing below I
certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §
240.14a-11.
|
|
|
|
|
CUSIP No. 03837C106
|
|
13G
|
|
Page
5
of 5 Pages
|
SIGNATURES
After reasonable inquiry and to the best of the undersigneds knowledge and belief, the undersigned certifies that the information set forth in this
statement is true, complete and correct.
DATED: January 18, 2019
|
|
|
By:
|
|
/s/ WILLIAM WEEKS VANDERFELT
|
William Weeks Vanderfelt
|
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Apr 2023 to Apr 2024